Latest Bayer Aktienges Ads (BAYRY) Headlines
BioElectronics Wins High Commendation In "Most Innovative New OTC Product Award" From OTC Bulletin
PR Newswire - Fri Mar 07, 8:49AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices won citations in two award categories from the OTC Bulletin, the leading global trade publication for over-the-counter healthcare products. The Smart Insole(TM) Heel Pain Therapy product was highly commended as the "Most Innovative New OTC Product Award" and the ActiPatch® Musculoskeletal Therapy was runner-up for its "Best New OTC Packaging Design Award."
Global Polylactic Acid (PLA) Market Report, 2020
M2 - Thu Mar 06, 9:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/mdf92j/polylactic_acid) has announced the addition of the "Global Polylactic Acid (PLA) Market Report, 2020: Packaging, Textile, Agriculture, Transportation, Bio-Medical, Electronics and Others" report to their offering. the global Polylactic Acid (PLA) market is expected to reach $5.2 billion by 2020 growing at a CAGR of 19.5% from 2013 to 2020 Polylactic Acid (PLA) is thermoplastic polyester derived from renewable feedstock such as corn starch, sugarcane, wheat and tapioca roots. PLA products contain bio-based renewable constituents. Limited fossil fuel resources and rising petrochemical price are the key factors driving the market. Limited fossil fuel resources, is an important reason for governments and companies to find substitutes to crude oil based products. Growing environmental concerns and government regulations is further assisting in adoption of PLA by end users of final products as well as manufacturers in industries such as textile, packaging, transportation, electronics, etc. However, there are certain factors that are hindering the growth of the market. Though PLA is a bio-based material and can be degraded completely, it requires specific industrial composting system to get completely degraded. Moreover, there are other renewable packaging alternatives hitting the market, for example agricultural fiber products produced using natural fibers such as bamboo, bagasse, bulrush and palm fiber. These alternatives might restraint the market growth. Reinforcement of PLA with other materials creates huge opportunities for future. As natural fibers are low cost and degradable, it's reinforcement with PLA leads to a material which is economical as well as ecological. New technologies are used to reinforce fiber in PLA so as to give it more strength and stiffness as well as many other features suitable for specific applications. Key Topics Covered: Chapter 1. Introduction Chapter 2. Executive Summary Chapter 3. Key Findings: Pla Market Study Chapter 4. Global Pla Market By Application Chapter 5. Pla Production And Raw Materials Chapter 6. Pla And Geographic Markets Chapter 7. Company Profiles - Bayer AG - Chemson Group - China Petroleum & Chemical Corporation (Sinopec) - Dow Chemical - DuPont Corporation - Eastman Chemical - Exxon Mobil Chemical - Mitsubishi Chemical Corporation (MCC) - Nova Chemicals Corporation - Nova Chemicals Corporation and Braskem S.A. For more information visit http://www.researchandmarkets.com/research/md...actic_acid
Global Textile Chemicals Market 2014-2018: Key Drivers in the Market Is the Increase in Demand for Finishing Chemicals
M2 - Thu Mar 06, 9:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/464tbj/global_textile) has announced the addition of the "Global Textile Chemicals Market 2014-2018" report to their offering. The analysts forecast the Global Textile Chemicals market to grow at a CAGR of 3.60 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased demand for finishing chemicals. The Global Textile Chemicals market has also been witnessing the development of eco-friendly products and bio-auxiliaries. However, the rising environmental concerns could pose a challenge to the growth of this market. Key vendors dominating this space are Archroma GmbH, BASF SE, Bayer AG, Dow Chemical Co., and Huntsman Corp. Other vendors mentioned in the report are Omnova Solutions Inc., Sumitomo Chemical Co. Ltd., Kiri Industries Ltd., The Lubrizol Corp., Huntsman Textile Effects Co. Ltd., and Pulcra Chemicals GmbH. Commenting on the report, an analyst from the team said: Traditional textile manufacturing consumes large amounts of energy, water, and chemicals, which is unsustainable and poses a threat to the environment. Chemical giants that manufacture textile chemicals are developing new products and technologies to enhance the sustainability of textile production. There is a rising demand for eco-friendly textiles and apparel in the Global Textiles market. Bio-auxiliaries, which are biodegradable and eco-friendly materials, are expected to bring in new solutions for textile wet processing. Using eco-friendly products also adds value to a manufacturer by differentiating its brand from competitors by eco-labeling. According to the report, one of the key drivers in the market is the increase in demand for finishing chemicals, which help in differentiating products by emphasizing product quality and enhancing comfort and durability. For more information visit http://www.researchandmarkets.com/research/46...al_textile About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Continuous Glucose Monitoring Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Thu Mar 06, 3:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/w77w6d/continuous) has announced the addition of the "Continuous Glucose Monitoring Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The rapid rise in diabetic population across the globe has considerably increased the demand for effective diabetes management systems. Currently, blood glucose meters are widely used for diabetes management; however, the trend is shifting towards minimally invasive (CGMS) or noninvasive glucose monitoring systems as these systems reduce the need for regular finger pricking and also lessen the pain. Continuous glucose monitoring systems are real time glucose sensing and monitoring devices that measure and display glucose levels of a patient at regular intervals. The usage of CGM is substantially increasing over traditional glucose monitoring systems as these systems are user friendly, provide access to real time values and trend, and provide enhanced accuracy. Additionally, it has been observed that continuous glucose monitoring significantly helps in diabetes management especially in type I diabetics, and helps in reducing long-term complications associated with diabetes. Increasing awareness in developed and developing economies, technological advancements and rising number of diabetic patients are some of the key factors that are expected to fuel the growth of this market. According to International Diabetes Federation (IDF) reports, approximately 382 million people globally were diagnosed with diabetes in 2013 and this number is expected to grow to 592 million by 2035. Additionally, as per Juvenile Diabetes Research Foundation (JDRF), the prevalence of type I diabetes rose by 23% in the U.S. between 2001 and 2009 for children under 20 years of age and is identified as the seventh leading cause of death in the country. Hence, rising number of patients suffering from type I diabetes is likely to increase the demand for CGMS. The continuous glucose monitoring market has been segmented on the basis of various CGM systems available in the market including Guardian Real Time CGM System, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4 Platinum and MiniMed Paradigm Revel/Veo CGM Systems. In 2012, the market for Guardian Real Time CGM system held the largest share globally, followed by Dexcom Seven Plus CGM system. However, during the forecast period 2013 to 2019, growth of the market for Guardian Real Time CGM system is expected to be slowest due to market saturation and development of innovative competitor products. Dexcom G4 Platinum CGM System market is expected to witness the fastest growth during the forecast period. FreeStyle Navigator that witnessed a decline in its market share in 2012 due to product recall from the U.S. market is anticipated to show significant growth during the forecast period due to expected launch of FreeStyle Navigator ll in 2014 in the U.S. market. Key Topics Covered: Preface Executive Summary Market Overview Continuous Glucose Monitoring (CGM) Market, by Device/Brand, 2011 - 2019 (USD Million) Global Continuous Glucose Monitoring Market Revenue, by Geography, 2011 - 2019 (USD Million) Competitive Landscape Recommendations Company Profiles List of Figures List of Tables Companies Mentioned - Abbott Laboratories - Bayer AG - Dexcom, Inc. - GlySens Incorporated - Insulet Corporation - Medtronic, Inc. - Nova Biomedical Corporation - Senseonics, Incorporated For more information visit http://www.researchandmarkets.com/research/w77w6d/continuous About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Update on Bayer/Regeneron's Eylea - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 3:55PM CST
Bayer announced that it has submitted a marketing authorization application for Eylea in Japan.
Foreign Firms Land 3 Pentagon Defense Contracts
Rich Smith, The Motley Fool - Motley Fool - Tue Mar 04, 10:16PM CST
After taking Monday off, the Department of Defense's acquisitions specialists got back to work today, awarding 18 separate defense contracts Tuesday, worth a total of $4.22 billion. Foreign-listed companies made out particularly well in this...
Regeneron's Eylea: The Anatomy Of A Blockbuster Drug
Todd Campbell, The Motley Fool - Motley Fool - Tue Mar 04, 5:30PM CST
Few drugs become multi-billion blockbusters, but those that do usually have similar characteristics. They treat big, and growing patient populations; they don't compete with too many other drugs (and outperform those that they do); and they have...
Bayer Up on Higher Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 10:10AM CST
Bayer's earnings during the fourth quarter of 2013 came in at $1.50 compared with $1.31 in the year-ago period.
Today's Biggest Biotech Stories: Roche, Regeneron, Cell Therapeutics, and AstraZeneca
Leo Sun, The Motley Fool - Motley Fool - Mon Mar 03, 8:28AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. Let's take a look at four stocks -- Roche , Regeneron , ...
Today's Top Biotech Stories: Ampio Pharmaceuticals, Auxilium Pharmaceuticals, Bayer, and Medivation
George Budwell, The Motley Fool - Motley Fool - Fri Feb 28, 8:15AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. Let's take a look at the top stories in biotech and health...
Concise Analysis of the International Bisphenol A Market
M2 - Fri Feb 28, 5:41AM CST
Research and Markets (http://www.researchandmarkets.com/research/9896sw/bisphenol_a) has announced the addition of the "Concise Analysis of the International Bisphenol A Market" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Bisphenol A in Thousand Metric Tons by the following End-Use Segments: - Polycarbonate Resins - Epoxy Resins - Others. The report profiles 33 companies including many key and niche players such as: - Bayer AG - Chang Chun Plastics Co. Ltd. - Kumho P&B Chemicals Inc. - LG Chem Ltd. - Mitsubishi Chemical Corporation - Mitsui Chemicals Inc. - Momentive Specialty Chemicals Inc. - Nan Ya Plastics Corporation - SABIC - The Dow Chemical Company Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Major Trends 3. Insights Into Major End-Use Markets 4. Regulatory Landscape 5. Product Overview 6. Bisphenol A Scorecard 7. Recent Industry Activity 8. Focus On Select Global Players 9. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 33 (including Divisions/Subsidiaries - 38) - The United States (9) - Japan (7) - Europe (6) - Germany (4) - Rest of Europe (2) - Asia-Pacific (Excluding Japan) (14) - Middle East (2) For more information visit http://www.researchandmarkets.com/research/98...isphenol_a
Bayer reports $4.35 billion full-year net profit
AP - Fri Feb 28, 3:01AM CST
BERLIN (AP) — Bayer AG says its net profit jumped by almost a third last year to 3.19 billion euros ($4.35 billion) as sales hit a record high.
Regeneron Pipeline Could Be The Big Story In 2014
at Investor's Business Daily - Thu Feb 27, 5:30PM CST
Biotech Regeneron Pharmaceuticals is shaping up to have an eventful year. Regeneron (REGN) has already become a leading stock thanks to the successful launch of Eylea, its treatment for wet age-related macular degeneration, a type of vision loss. It...
Global Postmenopausal Vaginal Atrophy Drug Forecast and Market Analysis to 2022
M2 - Thu Feb 27, 5:10AM CST
Research and Markets (http://www.researchandmarkets.com/research/bljhtv/pharmapoint) has announced the addition of the "PharmaPoint: Postmenopausal Vaginal Atrophy - Global Drug Forecast and Market Analysis to 2022" report to their offering. New Postmenopausal Vaginal Atrophy Therapeutics to Provide Boost for Market Growth and Female Libido The Postmenopausal Vaginal Atrophy (PVA) therapeutics market will double from $1 billion to approximately $2 billion over the next decade, with the US being the largest global contributor, according to a new report from research and consulting firm The authors. Between 2012 and 2022, the global PVA therapeutics market will grow at a Compound Annual Growth Rate (CAGR) of 6%. This will be backed significantly by the US market, which will climb from $976 million to $1.9 billion over the 10-year period, at a CAGR of 6.3%. Combined, the UK, France, Germany, Italy and Spain are expected to follow with a PVA therapeutics market revenue of $149 million in 2022, while the Japanese market will reach a value of $20 million by the same year. The launch of Shionogi's Osphena, which is a treatment for the large number of women suffering from dyspareunia, a prevalent symptom of PVA, is expected to be a significant market-driving force across these seven major markets in 2013. Meanwhile, Vaginorm could well dominate the global PVA market thanks to its potential of being black box warning-free, as well as its claims of helping to bolster female libido. Anita Angelica Moore, Therapy Analyst covering Oncology and Women's Health, says: Although the PVA market has experienced anemic growth over the past decade, it is expected to undergo considerable changes spurred by the launch of these products by 2014. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Disease Overview 4 Epidemiology 5 Disease Management 6 Competitive Assessment 7 Opportunity and Unmet Need 8 Pipeline Assessment 9 Current and Future Players 10 Market Outlook Companies Mentioned - Pfizer - Shionogi - Novo Nordisk - Actavis - Bayer AG For more information visit http://www.researchandmarkets.com/research/bl...harmapoint
Global Agrochemicals Market Report 2014 - Forecast to 2018: Type, Fertilizer Type, Pesticide Type, & Sub-Types
M2 - Wed Feb 26, 8:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/trbc87/agrochemicals) has announced the addition of the "Agrochemicals Market by Type, Fertilizer Type, Pesticide Type, & Sub-types - Global Market Trends & Forecast to 2018" report to their offering. The global agrochemicals market in terms of revenue was estimated to be worth $195,829.9 million in 2012 and is expected to reach $242,757.8 million by 2018, growing at a CAGR of 3.6% from 2013 to 2018. The global agrochemicals market is witnessing growth on account of increasing demand of grains for both edible and industrial applications. On the basis of use, agrochemicals are of two types: fertilizers and pesticides. Both of these can be used for agricultural and non-agricultural applications such as lawns and ornamental use. The mode of action of both types differs from each other. The former provides nutrient to the plants by being absorbed by the plant roots. The use of fertilizers is essential to improve nutrient profile of the soil and increase per hectare production. On the other hand, pesticides control the growth of unwanted plants and diseases such as weeds, fungus, bacteria, insects, etc. It is used to protect the crops (whether standing or stored) from harmful pests. Thus, the use of both fertilizers and pesticides is very important to support the growing demand of crops. Asia-Pacific and Latin America dominate the global agrochemicals market demand in 2012. Asia-Pacific is expected to remain the largest market in the near future owing to the increasing demand for food crops from its key countries-China and India. Asia-Pacific dominates the global agrochemicals market, accounting for major share in overall consumption in 2012. Latin and North America remained second and third largest markets for agrochemicals. The nutrient demand for corn is highest among crops such as wheat, cotton, sugarcane, etc. Hence, its production in North America (for bio-ethanol production also) is expected to increase the demand of agrochemicals in the region. Tight environment regulations in Europe are making it difficult for the manufacturers to launch products that comply with the existing regulations. The use of agrochemicals in the region is mainly used for food application. As for other use such as bio-polymers and bio-fuel, high construction and un-favorable economic condition is creating complex situation for the manufacturers. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Fertilizers Market 6 Pesticides Market 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles - Agrium Inc. - Basf S.E. - Bayer A.G. - Dow Agrosciences Llc. - E.I. Du Pont De Nemours & Company - Indian Farmers Fertiliser Cooperative - Israel Chemicals Ltd. - K S Ag - Makhteshim Agan Industries Ltd. - Monsanto Company - Mosaic Company - Nufarm Ltd. - Potash Corp. Sas. Inc. - Sociedad Quimica Y Minera De Chile Sa - Sumitomo Chemical - Syngenta Ag. - Uralkali - Yara International Asa For more information visit http://www.researchandmarkets.com/research/tr...ochemicals
Directory of Arts Foundations 2013
M2 - Wed Feb 26, 2:24AM CST
This comprehensive new directory lists every major national and international foundation, NGOs and other charitable and grant-making organizations around the world associated with the arts.
No Looking Back for Regeneron's Eylea - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 10:08AM CST
The FDA will review Regeneron's marketing application on Eylea for BRVO.
Bayer Progresses with Stivarga - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 4:00PM CST
Bayer announced the commencement of the patient enrolment process for a phase III study on Stivarga.
OncoMed Commences Study on OMP-54F28 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 3:50PM CST
OncoMed Pharma announced that it has commenced the third phase Ib study on OMP-54F28 in patients with platinum-sensitive ovarian cancer
Pipeline Progress at Bayer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 4:00PM CST
Bayer announced the initiation of the phase III EINSTEIN CHOICE study on Xarelto.
BioElectronics Wins High Commendation In "Most Innovative New OTC Product Award" From OTC Bulletin
PR Newswire - Fri Mar 07, 8:49AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices won citations in two award categories from the OTC Bulletin, the leading global trade publication for over-the-counter healthcare products. The Smart Insole(TM) Heel Pain Therapy product was highly commended as the "Most Innovative New OTC Product Award" and the ActiPatch® Musculoskeletal Therapy was runner-up for its "Best New OTC Packaging Design Award."
Global Polylactic Acid (PLA) Market Report, 2020
M2 - Thu Mar 06, 9:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/mdf92j/polylactic_acid) has announced the addition of the "Global Polylactic Acid (PLA) Market Report, 2020: Packaging, Textile, Agriculture, Transportation, Bio-Medical, Electronics and Others" report to their offering. the global Polylactic Acid (PLA) market is expected to reach $5.2 billion by 2020 growing at a CAGR of 19.5% from 2013 to 2020 Polylactic Acid (PLA) is thermoplastic polyester derived from renewable feedstock such as corn starch, sugarcane, wheat and tapioca roots. PLA products contain bio-based renewable constituents. Limited fossil fuel resources and rising petrochemical price are the key factors driving the market. Limited fossil fuel resources, is an important reason for governments and companies to find substitutes to crude oil based products. Growing environmental concerns and government regulations is further assisting in adoption of PLA by end users of final products as well as manufacturers in industries such as textile, packaging, transportation, electronics, etc. However, there are certain factors that are hindering the growth of the market. Though PLA is a bio-based material and can be degraded completely, it requires specific industrial composting system to get completely degraded. Moreover, there are other renewable packaging alternatives hitting the market, for example agricultural fiber products produced using natural fibers such as bamboo, bagasse, bulrush and palm fiber. These alternatives might restraint the market growth. Reinforcement of PLA with other materials creates huge opportunities for future. As natural fibers are low cost and degradable, it's reinforcement with PLA leads to a material which is economical as well as ecological. New technologies are used to reinforce fiber in PLA so as to give it more strength and stiffness as well as many other features suitable for specific applications. Key Topics Covered: Chapter 1. Introduction Chapter 2. Executive Summary Chapter 3. Key Findings: Pla Market Study Chapter 4. Global Pla Market By Application Chapter 5. Pla Production And Raw Materials Chapter 6. Pla And Geographic Markets Chapter 7. Company Profiles - Bayer AG - Chemson Group - China Petroleum & Chemical Corporation (Sinopec) - Dow Chemical - DuPont Corporation - Eastman Chemical - Exxon Mobil Chemical - Mitsubishi Chemical Corporation (MCC) - Nova Chemicals Corporation - Nova Chemicals Corporation and Braskem S.A. For more information visit http://www.researchandmarkets.com/research/md...actic_acid
Global Textile Chemicals Market 2014-2018: Key Drivers in the Market Is the Increase in Demand for Finishing Chemicals
M2 - Thu Mar 06, 9:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/464tbj/global_textile) has announced the addition of the "Global Textile Chemicals Market 2014-2018" report to their offering. The analysts forecast the Global Textile Chemicals market to grow at a CAGR of 3.60 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased demand for finishing chemicals. The Global Textile Chemicals market has also been witnessing the development of eco-friendly products and bio-auxiliaries. However, the rising environmental concerns could pose a challenge to the growth of this market. Key vendors dominating this space are Archroma GmbH, BASF SE, Bayer AG, Dow Chemical Co., and Huntsman Corp. Other vendors mentioned in the report are Omnova Solutions Inc., Sumitomo Chemical Co. Ltd., Kiri Industries Ltd., The Lubrizol Corp., Huntsman Textile Effects Co. Ltd., and Pulcra Chemicals GmbH. Commenting on the report, an analyst from the team said: Traditional textile manufacturing consumes large amounts of energy, water, and chemicals, which is unsustainable and poses a threat to the environment. Chemical giants that manufacture textile chemicals are developing new products and technologies to enhance the sustainability of textile production. There is a rising demand for eco-friendly textiles and apparel in the Global Textiles market. Bio-auxiliaries, which are biodegradable and eco-friendly materials, are expected to bring in new solutions for textile wet processing. Using eco-friendly products also adds value to a manufacturer by differentiating its brand from competitors by eco-labeling. According to the report, one of the key drivers in the market is the increase in demand for finishing chemicals, which help in differentiating products by emphasizing product quality and enhancing comfort and durability. For more information visit http://www.researchandmarkets.com/research/46...al_textile About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Continuous Glucose Monitoring Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Thu Mar 06, 3:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/w77w6d/continuous) has announced the addition of the "Continuous Glucose Monitoring Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The rapid rise in diabetic population across the globe has considerably increased the demand for effective diabetes management systems. Currently, blood glucose meters are widely used for diabetes management; however, the trend is shifting towards minimally invasive (CGMS) or noninvasive glucose monitoring systems as these systems reduce the need for regular finger pricking and also lessen the pain. Continuous glucose monitoring systems are real time glucose sensing and monitoring devices that measure and display glucose levels of a patient at regular intervals. The usage of CGM is substantially increasing over traditional glucose monitoring systems as these systems are user friendly, provide access to real time values and trend, and provide enhanced accuracy. Additionally, it has been observed that continuous glucose monitoring significantly helps in diabetes management especially in type I diabetics, and helps in reducing long-term complications associated with diabetes. Increasing awareness in developed and developing economies, technological advancements and rising number of diabetic patients are some of the key factors that are expected to fuel the growth of this market. According to International Diabetes Federation (IDF) reports, approximately 382 million people globally were diagnosed with diabetes in 2013 and this number is expected to grow to 592 million by 2035. Additionally, as per Juvenile Diabetes Research Foundation (JDRF), the prevalence of type I diabetes rose by 23% in the U.S. between 2001 and 2009 for children under 20 years of age and is identified as the seventh leading cause of death in the country. Hence, rising number of patients suffering from type I diabetes is likely to increase the demand for CGMS. The continuous glucose monitoring market has been segmented on the basis of various CGM systems available in the market including Guardian Real Time CGM System, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4 Platinum and MiniMed Paradigm Revel/Veo CGM Systems. In 2012, the market for Guardian Real Time CGM system held the largest share globally, followed by Dexcom Seven Plus CGM system. However, during the forecast period 2013 to 2019, growth of the market for Guardian Real Time CGM system is expected to be slowest due to market saturation and development of innovative competitor products. Dexcom G4 Platinum CGM System market is expected to witness the fastest growth during the forecast period. FreeStyle Navigator that witnessed a decline in its market share in 2012 due to product recall from the U.S. market is anticipated to show significant growth during the forecast period due to expected launch of FreeStyle Navigator ll in 2014 in the U.S. market. Key Topics Covered: Preface Executive Summary Market Overview Continuous Glucose Monitoring (CGM) Market, by Device/Brand, 2011 - 2019 (USD Million) Global Continuous Glucose Monitoring Market Revenue, by Geography, 2011 - 2019 (USD Million) Competitive Landscape Recommendations Company Profiles List of Figures List of Tables Companies Mentioned - Abbott Laboratories - Bayer AG - Dexcom, Inc. - GlySens Incorporated - Insulet Corporation - Medtronic, Inc. - Nova Biomedical Corporation - Senseonics, Incorporated For more information visit http://www.researchandmarkets.com/research/w77w6d/continuous About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Update on Bayer/Regeneron's Eylea - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 3:55PM CST
Bayer announced that it has submitted a marketing authorization application for Eylea in Japan.
Foreign Firms Land 3 Pentagon Defense Contracts
Rich Smith, The Motley Fool - Motley Fool - Tue Mar 04, 10:16PM CST
After taking Monday off, the Department of Defense's acquisitions specialists got back to work today, awarding 18 separate defense contracts Tuesday, worth a total of $4.22 billion. Foreign-listed companies made out particularly well in this...
Regeneron's Eylea: The Anatomy Of A Blockbuster Drug
Todd Campbell, The Motley Fool - Motley Fool - Tue Mar 04, 5:30PM CST
Few drugs become multi-billion blockbusters, but those that do usually have similar characteristics. They treat big, and growing patient populations; they don't compete with too many other drugs (and outperform those that they do); and they have...
Bayer Up on Higher Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 10:10AM CST
Bayer's earnings during the fourth quarter of 2013 came in at $1.50 compared with $1.31 in the year-ago period.
Today's Biggest Biotech Stories: Roche, Regeneron, Cell Therapeutics, and AstraZeneca
Leo Sun, The Motley Fool - Motley Fool - Mon Mar 03, 8:28AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. Let's take a look at four stocks -- Roche , Regeneron , ...
Today's Top Biotech Stories: Ampio Pharmaceuticals, Auxilium Pharmaceuticals, Bayer, and Medivation
George Budwell, The Motley Fool - Motley Fool - Fri Feb 28, 8:15AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. Let's take a look at the top stories in biotech and health...
Concise Analysis of the International Bisphenol A Market
M2 - Fri Feb 28, 5:41AM CST
Research and Markets (http://www.researchandmarkets.com/research/9896sw/bisphenol_a) has announced the addition of the "Concise Analysis of the International Bisphenol A Market" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Bisphenol A in Thousand Metric Tons by the following End-Use Segments: - Polycarbonate Resins - Epoxy Resins - Others. The report profiles 33 companies including many key and niche players such as: - Bayer AG - Chang Chun Plastics Co. Ltd. - Kumho P&B Chemicals Inc. - LG Chem Ltd. - Mitsubishi Chemical Corporation - Mitsui Chemicals Inc. - Momentive Specialty Chemicals Inc. - Nan Ya Plastics Corporation - SABIC - The Dow Chemical Company Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Major Trends 3. Insights Into Major End-Use Markets 4. Regulatory Landscape 5. Product Overview 6. Bisphenol A Scorecard 7. Recent Industry Activity 8. Focus On Select Global Players 9. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 33 (including Divisions/Subsidiaries - 38) - The United States (9) - Japan (7) - Europe (6) - Germany (4) - Rest of Europe (2) - Asia-Pacific (Excluding Japan) (14) - Middle East (2) For more information visit http://www.researchandmarkets.com/research/98...isphenol_a
Bayer reports $4.35 billion full-year net profit
AP - Fri Feb 28, 3:01AM CST
BERLIN (AP) — Bayer AG says its net profit jumped by almost a third last year to 3.19 billion euros ($4.35 billion) as sales hit a record high.
Regeneron Pipeline Could Be The Big Story In 2014
at Investor's Business Daily - Thu Feb 27, 5:30PM CST
Biotech Regeneron Pharmaceuticals is shaping up to have an eventful year. Regeneron (REGN) has already become a leading stock thanks to the successful launch of Eylea, its treatment for wet age-related macular degeneration, a type of vision loss. It...
Global Postmenopausal Vaginal Atrophy Drug Forecast and Market Analysis to 2022
M2 - Thu Feb 27, 5:10AM CST
Research and Markets (http://www.researchandmarkets.com/research/bljhtv/pharmapoint) has announced the addition of the "PharmaPoint: Postmenopausal Vaginal Atrophy - Global Drug Forecast and Market Analysis to 2022" report to their offering. New Postmenopausal Vaginal Atrophy Therapeutics to Provide Boost for Market Growth and Female Libido The Postmenopausal Vaginal Atrophy (PVA) therapeutics market will double from $1 billion to approximately $2 billion over the next decade, with the US being the largest global contributor, according to a new report from research and consulting firm The authors. Between 2012 and 2022, the global PVA therapeutics market will grow at a Compound Annual Growth Rate (CAGR) of 6%. This will be backed significantly by the US market, which will climb from $976 million to $1.9 billion over the 10-year period, at a CAGR of 6.3%. Combined, the UK, France, Germany, Italy and Spain are expected to follow with a PVA therapeutics market revenue of $149 million in 2022, while the Japanese market will reach a value of $20 million by the same year. The launch of Shionogi's Osphena, which is a treatment for the large number of women suffering from dyspareunia, a prevalent symptom of PVA, is expected to be a significant market-driving force across these seven major markets in 2013. Meanwhile, Vaginorm could well dominate the global PVA market thanks to its potential of being black box warning-free, as well as its claims of helping to bolster female libido. Anita Angelica Moore, Therapy Analyst covering Oncology and Women's Health, says: Although the PVA market has experienced anemic growth over the past decade, it is expected to undergo considerable changes spurred by the launch of these products by 2014. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Disease Overview 4 Epidemiology 5 Disease Management 6 Competitive Assessment 7 Opportunity and Unmet Need 8 Pipeline Assessment 9 Current and Future Players 10 Market Outlook Companies Mentioned - Pfizer - Shionogi - Novo Nordisk - Actavis - Bayer AG For more information visit http://www.researchandmarkets.com/research/bl...harmapoint
Global Agrochemicals Market Report 2014 - Forecast to 2018: Type, Fertilizer Type, Pesticide Type, & Sub-Types
M2 - Wed Feb 26, 8:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/trbc87/agrochemicals) has announced the addition of the "Agrochemicals Market by Type, Fertilizer Type, Pesticide Type, & Sub-types - Global Market Trends & Forecast to 2018" report to their offering. The global agrochemicals market in terms of revenue was estimated to be worth $195,829.9 million in 2012 and is expected to reach $242,757.8 million by 2018, growing at a CAGR of 3.6% from 2013 to 2018. The global agrochemicals market is witnessing growth on account of increasing demand of grains for both edible and industrial applications. On the basis of use, agrochemicals are of two types: fertilizers and pesticides. Both of these can be used for agricultural and non-agricultural applications such as lawns and ornamental use. The mode of action of both types differs from each other. The former provides nutrient to the plants by being absorbed by the plant roots. The use of fertilizers is essential to improve nutrient profile of the soil and increase per hectare production. On the other hand, pesticides control the growth of unwanted plants and diseases such as weeds, fungus, bacteria, insects, etc. It is used to protect the crops (whether standing or stored) from harmful pests. Thus, the use of both fertilizers and pesticides is very important to support the growing demand of crops. Asia-Pacific and Latin America dominate the global agrochemicals market demand in 2012. Asia-Pacific is expected to remain the largest market in the near future owing to the increasing demand for food crops from its key countries-China and India. Asia-Pacific dominates the global agrochemicals market, accounting for major share in overall consumption in 2012. Latin and North America remained second and third largest markets for agrochemicals. The nutrient demand for corn is highest among crops such as wheat, cotton, sugarcane, etc. Hence, its production in North America (for bio-ethanol production also) is expected to increase the demand of agrochemicals in the region. Tight environment regulations in Europe are making it difficult for the manufacturers to launch products that comply with the existing regulations. The use of agrochemicals in the region is mainly used for food application. As for other use such as bio-polymers and bio-fuel, high construction and un-favorable economic condition is creating complex situation for the manufacturers. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Fertilizers Market 6 Pesticides Market 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles - Agrium Inc. - Basf S.E. - Bayer A.G. - Dow Agrosciences Llc. - E.I. Du Pont De Nemours & Company - Indian Farmers Fertiliser Cooperative - Israel Chemicals Ltd. - K S Ag - Makhteshim Agan Industries Ltd. - Monsanto Company - Mosaic Company - Nufarm Ltd. - Potash Corp. Sas. Inc. - Sociedad Quimica Y Minera De Chile Sa - Sumitomo Chemical - Syngenta Ag. - Uralkali - Yara International Asa For more information visit http://www.researchandmarkets.com/research/tr...ochemicals
Directory of Arts Foundations 2013
M2 - Wed Feb 26, 2:24AM CST
This comprehensive new directory lists every major national and international foundation, NGOs and other charitable and grant-making organizations around the world associated with the arts.
No Looking Back for Regeneron's Eylea - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 10:08AM CST
The FDA will review Regeneron's marketing application on Eylea for BRVO.
Bayer Progresses with Stivarga - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 4:00PM CST
Bayer announced the commencement of the patient enrolment process for a phase III study on Stivarga.
OncoMed Commences Study on OMP-54F28 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 3:50PM CST
OncoMed Pharma announced that it has commenced the third phase Ib study on OMP-54F28 in patients with platinum-sensitive ovarian cancer
Pipeline Progress at Bayer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 4:00PM CST
Bayer announced the initiation of the phase III EINSTEIN CHOICE study on Xarelto.
